Indegene Limited carries a market capitalization of 119.04B, placing it among publicly traded companies globally. Its enterprise value stands at 137.46B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 119.04B |
| Enterprise Value | 137.46B |
Indegene Limited trades at a trailing price-to-earnings ratio of 31.57.
| PE Ratio | 31.57 |
| PS Ratio | 4.70 |
| PB Ratio | N/A |
| P/TBV Ratio | N/A |
| P/FCF Ratio | N/A |
| P/OCF Ratio | N/A |
On an enterprise value basis, Indegene Limited trades at an EV/EBITDA multiple of 28.70 and an EV/FCF ratio of 1,289.44. The EV/Sales ratio of 4.70 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 28.70 provides insight into valuation relative to core operating earnings.
| EV / Sales | 4.70 |
| EV / EBITDA | 28.70 |
| EV / EBIT | 28.70 |
| EV / FCF | 1,289.44 |
Indegene Limited maintains a current ratio of 8.97, meaning it holds 9.0x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 7.62, indicating elevated leverage, while an interest coverage ratio of 34.21 demonstrates strong ability to service its debt obligations.
| Current Ratio | 8.97 |
| Quick Ratio | 5.87 |
| Debt / Equity | 7.62 |
| Debt / EBITDA | N/A |
| Interest Coverage | 34.21 |
| Return on Equity (ROE) | N/A |
| Return on Assets (ROA) | N/A |
| Return on Invested Capital (ROIC) | N/A |
| Return on Capital Employed (ROCE) | 731.70 |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | N/A |
Over the trailing twelve months, Indegene Limited has paid 1.36B in income taxes, reflecting an effective tax rate of 23.85.
| Income Tax | 1.36B |
| Effective Tax Rate | 23.85 |
Indegene Limited's stock has declined approximately -13.02473% over the past 52 weeks. The 50-day moving average sits at 518.12, while the 200-day moving average is 507.88.
| Beta (5Y) | N/A |
| 52-Week Price Change | -13.02473% |
| 50-Day Moving Average | 518.12 |
| 200-Day Moving Average | 507.88 |
| Average Volume (20 Days) | N/A |
Over the trailing twelve months, Indegene Limited generated 29.24B in revenue and converted that into 4.35B in net income, yielding earnings per share of 18.05. EBITDA reached 4.79B, while operating income came in at 4.79B.
| Revenue | 29.24B |
| Gross Profit | N/A |
| Operating Income | 4.79B |
| Pretax Income | 5.72B |
| Net Income | 4.35B |
| EBITDA | 4.79B |
| EBIT | 4.79B |
| Earnings Per Share (EPS) | 18.05 |
Indegene Limited operates with a gross margin of 100.00, reflecting its pricing power and cost economics. The operating margin of 16.38 and net profit margin of 14.89 provide insight into operational efficiency.
| Gross Margin | 100.00 |
| Operating Margin | 16.38 |
| Pretax Margin | 19.56 |
| Profit Margin | 14.89 |
| EBITDA Margin | 16.38 |
Indegene Limited posts an Altman Z-Score of 31.59, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | 31.59 |